Showing results (41-50 of 76) with videos related to
Sort By:
Pageof 8
Frontiers in Oncology|May 3, 2021
Case Report: Pseudomeningeosis and Demyelinating Metastasis-Like Lesions From Checkpoint Inhibitor Therapy in Malignant MelanomaTeresa Schmidt, Sied Kebir, Elisabeth Livingstone, et al.European Journal of Cancer (Oxford, England : 1990)|October 22, 2020
Drug repositioning of antiretroviral ritonavir for combinatorial therapy in glioblastomaLaurèl Rauschenbach, Anja Wieland, Roman Reinartz, et al.Journal of Cancer Research and Clinical Oncology|April 22, 2016
Phase I trial of dovitinib (TKI258) in recurrent glioblastomaNiklas Schäfer, Gerrit H Gielen, Sied Kebir, et al.Oncology|September 7, 2013
FLAIR-only progression in bevacizumab-treated relapsing glioblastoma does not predict short survivalChristina Schaub, Susanne Greschus, Mirko Seifert, et al.Journal of Neuro-Oncology|May 20, 2016
Prognostic factors in recurrent glioblastoma patients treated with bevacizumabChristina Schaub, Julia Tichy, Niklas Schäfer, et al.Journal of Applied Clinical Medical Physics|January 3, 2021
Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF-phase I/II trialYouness Nour, Christoph Pöttgen, Sied Kebir, et al.Nuclear Medicine Communications|October 12, 2023
Correlation of the apparent diffusion coefficient with the standardized uptake value in meningioma of the skull plane using [68]Ga-DOTATOC PET/MRIAleksandar Milosevic, Hanna Styczen, Johannes Haubold, et al.Journal of Cancer Research and Clinical Oncology|August 11, 2022
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent gliomaLazaros Lazaridis, Teresa Schmidt, Christoph Oster, et al.European Journal of Cancer (Oxford, England : 1990)|March 31, 2021
Leptomeningeal disease from melanoma-Poor prognosis despite new therapeutic modalitiesEleftheria Chorti, Sied Kebir, Misbah S Ahmed, et al.Journal of Cancer Research and Clinical Oncology|December 13, 2019
Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastomaLazaros Lazaridis, Niklas Schäfer, Sarah Teuber-Hanselmann, et al.Pageof 8